The path well traveled: Using mammalian retroviruses to guide research on XMRV

Molecular Interventions

Volumn 10, Issue 1, 2010, Pages 20-24

  Lee, KyeongEun ^a   Jones, Kathryn S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS DNA;

CANCER PATIENT; CHRONIC FATIGUE SYNDROME; DNA ISOLATION; DNA SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; MURINE LEUKEMIA VIRUS; NONHUMAN; PROSTATE CANCER; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; VIRUS DETECTION; VIRUS TRANSMISSION; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS;

ANTI-RETROVIRAL AGENTS; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; PROSTATIC NEOPLASMS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 76149101596     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.10.1.5     Document Type: Review

References (26)

1. Poiesz B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D., and Gallo, R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 77, 7415-7419 (1980). This paper reports the discovery of the first human retrovirus, HTLV-1.
2. Verdonck, K., Gonzalez, E., Van Dooren, S., Vandamme, A.M., Vanham, G., and Gotuzzo, E. Human T-lymphotropic virus 1: Recent knowledge about an ancient infection. Lancet Infect. Dis. 7, 266-281 (2007).
3. Urisman, A., Molinaro, R.J., Fischer, N. et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2, e25 (2006). This paper describes the discovery of XMRV, in tissues from prostate cancer patients.
4. Lombardi, V.C., Ruscetti, F.W., Das Gupta, J. et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326, 585-589 (2009). This was the first paper to show a link between XMRV and CFS. It was also the first to show that infectious XMRV could be isolated from infected individuals, and that many of these individuals mounted an immune response against XMRV.
5. Levy, J.A. Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains. Science 182, 1151-1153 (1973).
6. Knouf, E.C., Metzger, M.J., Mitchell, P.S., Arroyo, J.D., Chevillet, J.R., Tewari, M., and Miller, A.D. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J. Virol. 83, 7353-7356 (2009). This is the first report of a cell line, isolated from an individual with prostate cancer, that expresses XMRV.
7. Schlaberg, R., Choe, D.J., Brown, K.R., Thaker, H.M., and Singh, I.R. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc. Natl. Acad. Sci. U.S.A. 106, 16351-16356 (2009). This manuscript was the first to report the presence of XMRV in malignant cells, and the expression of XMRV proteins, in prostate cancer tissue.
8. Fischer, N., Hellwinkel, O., Schulz, C., Chun, F.K., Huland, H., Aepfelbacher, M., and Schlomm, T. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J. Clin. Virol. 43, 277-283 (2008).
9. Hohn, O., Krause, H., Barbarotto, P., Niederstadt, L., Beimforde, N., Denner, J., Miller, K., Kurth, R., and Bannert, N. Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 6, 92 (2009).
10. Rodriguez, J.J. and Goff, S.P. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J. Virol. [Epub ahead of print] doi:10.1128/JVI.01969-09 (2009).
11. Corcoran, L.M., Adams, J.M., Dunn, A.R., and Cory, S. Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell 37, 113-122 (1984).
12. Neil, J.C., Hughes, D., McFarlane, R., Wilkie, N.M., Onions, D.E., Lees, G., and Jarrett, O. Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature 308, 814-820 (1984).
13. Dong, B., Kim, S., Hong, S. et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. U.S.A. 104, 1655-1660 (2007). The authors of this manuscript were the first to generate an infectious molecular clone of XMRV, and to provide evidence that Xpr1 is a receptor for XMRV.
14. Kim, S., Kim, N., Dong, B. et al. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J. Virol. 82, 9964-9977 (2008).
15. Battini, J.L., Rasko, J.E., and Miller, A.D. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: Possible role in G protein-coupled signal transduction. Proc. Natl. Acad. Sci. U.S.A. 96, 1385-1390 (1999). This is one of three papers that discovered that Xpr-1 is the receptor for xenotropic and polytropic murine leukemia viruses.
16. Tailor, C.S., Nouri, A., Lee, C.G., Kozak, C., and Kabat, D. Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc. Natl. Acad. Sci. U.S.A. 96, 927-932 (1999). This is one of three papers that identified Xpr-1 as the receptor for xenotropic and polytropic murine leukemia viruses.
17. Yang, Y.L., Guo, L., Xu, S., Holland, C.A., Kitamura, T., Hunter, K., and Cunningham, J.M. Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat. Genet. 21, 216-219 (1999). This is one of three papers that discovered that Xpr-1 is the receptor for xenotropic and polytropic murine leukemia viruses.
18. Marin, M., Tailor, C.S., Nouri, A., Kozak, S.L., and Kabat, D. Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses. J. Virol. 73, 9362-9368 (1999).
19. Yan, Y., Liu, Q., and Kozak, C.A. Six host range variants of the xenotropic/polytropic gammaretroviruses define determinants for entry in the XPR1 cell surface receptor. Retrovirology 6, 87 (2009).
20. Bazarbachi, A. and Hermine, O. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 (Suppl 1), S186-S190 (1996).
21. Gill, P.S., Harrington, W., Jr., Kaplan, M.H. et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N. Engl. J. Med. 332, 1744-1748 (1995).
22. Hermine, O., Bouscary, D., Gessain, A. et al. Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N. Engl. J. Med. 332, 1749-1751 (1995).
23. Sakuma, R., Sakuma, T., Ohmine, S., Silverman, R.H., and Ikeda, Y. Xenotropic murine leukemia virus-related virus is susceptible to AZT. Virology [Epub ahead of print] doi:10.1016/j.virol.2009.11.013 (2009). This manuscript is the first to identify an anti-retroviral drug (AZT) that inhibits XMRV replication.
24. Adamson, C.S. and Freed, E.O. Anti-HIV-1 therapeutics: From FDA-approved drugs to hypothetical future targets. Mol. Interv. 9, 70-74 (2009).
25. Sparkes, A.H. Feline leukaemia virus: A review of immunity and vaccination. J. Small Anim. Pract. 38, 187-194 (1997).
26. Torres, A.N., O'Halloran, K.P., Larson, L.J., Schultz, R.D., and Hoover, E.A. Feline leukemia virus immunity induced by whole inactivated virus vaccination. Vet. Immunol. Immunopathol. [Epub ahead of print] doi:10.1016/j.vetimm.2009.10.017 (2009).